Additionally, iTILs-TIM-3+ are more prone to be detected in triple-negative basal-like breast cancer, with sTILs-TIM-3+ being detected mostly in luminal A and luminal B mammary carcinomas, in contrast with the HER-2+ and the triple-negative mammary carcinomas [38]. The gene discussed is ERBB2; the disease is breast carcinoma.